# Sanara (SMTI) — News

SMTI · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/smti/news

## Recent headlines

- [Wh Smith PLC: Panmure Liberum initiates coverage with buy rating; target price 420p](https://www.ainvest.com/news/wh-smith-plc-panmure-liberum-initiates-coverage-buy-rating-target-price-420p-2610) — AInvest Wire, Oct 12, 2026
  Panmure Liberum has initiated coverage on WH Smith PLC (SMWH), assigning the stock a "buy" rating and setting a target price of 420p per share. The firm's decision follows a comprehensive analysis of the company’s market position, operational performance, and growth potential. While no recent price…
- [Sanara MedTech Q2 revenue USD 28.1 million](https://www.ainvest.com/news/sanara-medtech-q2-revenue-usd-28-1-million-2608) — AInvest Wire, Aug 11, 2026
- [Sanara MedTech Inc: H.C. Wainwright cuts to neutral from buy; cuts target price to $35 from $36](https://www.ainvest.com/news/sanara-medtech-wainwright-cuts-neutral-buy-cuts-target-price-35-36-2607) — AInvest Wire, Jul 30, 2026
  H.C. Wainwright has downgraded its rating for Sanara MedTech (NASDAQ:SMTI) from "Buy" to "Neutral" and reduced its price target to $35 from $36, effective July 30, 2026. This adjustment follows the firm’s reassessment of the company’s financial performance and strategic outlook. The analyst firm…
- [Sanara MedTech - pays no fee or penalty for termination of services agreement - SEC filing](https://www.ainvest.com/news/sanara-medtech-pays-fee-penalty-termination-services-agreement-sec-filing-2606) — AInvest Wire, Jun 4, 2026
- [Sanara MedTech - shifts strategy to focus on soft tissue repair and bone fusion products - SEC filing](https://www.ainvest.com/news/sanara-medtech-shifts-strategy-focus-soft-tissue-repair-bone-fusion-products-sec-filing-2606) — AInvest Wire, Jun 4, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).